Joseph Sutton

Biomarker Studies Asset Manager Roche

As a Biomarker Studies Asset Manager at Roche, Joseph supports global clinical development programs by leading the operational delivery of biomarker and companion diagnostic strategies. Working across cross-functional teams and external laboratory partners, they oversee the execution of biomarker initiatives to ensure the delivery of high-quality biomarker data that supports Phase I-III clinical trials and advances precision medicine in drug development.

Seminars

Tuesday 1st December 2026
Managing Multi-Site Biomarker Collection, Processing & Logistics – Ensuring Sample Integrity, Data Quality & Operational Success Across Global Trials
9:00 am
  • Learn how to operationalise complex biomarker strategies across global clinical trials by standardising sample collection, processing and logistics to maintain sample integrity and generate reliable biomarker data
  • Discover how to successfully implement advanced biomarker assays in real world trial settings through effective site training, streamlined workflows, regulatory compliant processes and high-quality sample management across diverse regions
  • Explore strategies for balancing scientific objectives with operational feasibility through thoughtful protocol design, reduced burden on patients and sites and effective partnerships with central laboratories and biomarker service providers
Joseph Sutton - Expert Speaker for Novel CNS Biomarkers Summit Europe